Top Markets
Coin of the day
Pharmanutra S.p.A. Pharmanutra S.p.A.

Pharmanutra S.p.A.

PHN
Rank in Stocks #9895
Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise,... Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.
Share Price
$97.03
Last synced: 2026-08-28
Market Cap
$929.06M
Change (1 day)
-0.12%
Change (1 year)
70.33%
Country
IT
Trade Pharmanutra S.p.A. (PHN)

Category

Stock price history for Pharmanutra S.p.A. (PHN)
Highest end of day price: $98.04 on 2026-08-01

Lowest end of day price: $15.45 on 2017-07-01
Stock price history of Pharmanutra S.p.A. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 25.33%
2025 11.38%
2024 -5.90%
2023 -8.56%
2022 -20.09%
2021 94.88%
2020 71.55%
2019 41.28%
2018 16.53%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN